RPT-Market Chatter-Corporate finance press digest
Feb 6 (Reuters) - The following corporate finance-related stories were reported by media on Wednesday:
* Softbank Corp will issue $3.2 billion in corporate bonds, the biggest ever by a non-financial Japanese firm to retail investors, to convert part of the $17.7 billion in short-term loans used to purchase Sprint Nextel Corp to longer term debt, two sources familiar with the matter said.
* Online scrapbook Pinterest is trying to raise a new round of funding that would give it a valuation of $2 billion to $2.5 billion, the Wall Street Journal reported.
* Turkey's Cukurova Holding is determined to recover a disputed stake in Turkcell from Russian partner Altimo and is seeking a loan of up to $2 billion to do so, sources familiar with the situation said.
* The head of Royal Bank of Scotland's investment banking arm is set to give up a bonus pot worth 4 million pounds ($6.27 million) as he resigns from the lender over its involvement in Libor-rigging, The Telegraph reported.
* Walt Disney is "exploring an exit" of ESPN from the UK, after the sports network incurred losses and lost key sports rights contracts, the Financial Times reported.
* Banco Espirito Santo, Portugal's second largest listed bank by assets, is considering making an offer to buy Spain's Banco Gallego, two sources said.
- Tweet this
- Share this
- Digg this
- U.S. strikes have slowed Iraq militants but not weakened them - Pentagon
- CBI drops coal scam case against Kumar Mangalam Birla
- India's growth speeds up in after-glow of Modi's triumph
- Exclusive: Reliance plans $13 billion projects including new refinery
- Saudi king warns of terrorism threat to U.S., Europe
The Central Bureau of Investigation (CBI) has closed a coal scam case against billionaire Kumar Mangalam Birla and a former top bureaucrat that emerged in 2012 after an auditor's report on revenue loss to the exchequer from allocations of coal blocks. Full Article
Exclusive: Reliance plans $13 billion projects including new refinery. Full Article
In race for bigger margins, drug makers willing to lose the India "advantage". Full Article